Melioidosis Vaccines (MeVa): Attitudes to vaccines, melioidosis and clinical trials in key stakeholders in Ubon Ratchathani, Thailand

Background: Melioidosis is a bacterial infection which kills an estimated 89,000 people per year in tropical and sub-tropical regions, chiefly affecting the poorest. Diabetes is the primary risk factor, conferring a 12-fold increase in risk. Despite limited funding compared to other neglected tropic...

Descripción completa

Detalles Bibliográficos
Autores principales: Khirikoekkong, Napat, Asarath, Supa-at, Hill, Jennifer, Wettana, Benjawan, Srisawang, Orathai, Cheah, Phaik Yeong, Dunachie, Susanna, Chamnan, Parinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646340/
https://www.ncbi.nlm.nih.gov/pubmed/37969481
http://dx.doi.org/10.12688/wellcomeopenres.18383.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646340/
https://www.ncbi.nlm.nih.gov/pubmed/37969481
http://dx.doi.org/10.12688/wellcomeopenres.18383.1

Ejemplares similares